nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—DRD1—brainstem—narcolepsy	0.0119	0.0948	CbGeAlD
Triflupromazine—DRD1—forebrain—narcolepsy	0.0115	0.0915	CbGeAlD
Triflupromazine—CHRM2—forebrain—narcolepsy	0.00923	0.0737	CbGeAlD
Triflupromazine—CHRM1—forebrain—narcolepsy	0.0084	0.0671	CbGeAlD
Triflupromazine—HTR2B—forebrain—narcolepsy	0.00836	0.0668	CbGeAlD
Triflupromazine—DRD1—midbrain—narcolepsy	0.00756	0.0604	CbGeAlD
Triflupromazine—DRD2—brainstem—narcolepsy	0.00701	0.056	CbGeAlD
Triflupromazine—DRD2—forebrain—narcolepsy	0.00677	0.054	CbGeAlD
Triflupromazine—BCHE—brainstem—narcolepsy	0.00636	0.0508	CbGeAlD
Triflupromazine—BCHE—forebrain—narcolepsy	0.00614	0.049	CbGeAlD
Triflupromazine—DRD1—brain—narcolepsy	0.00475	0.038	CbGeAlD
Triflupromazine—Cyamemazine—HTR2A—narcolepsy	0.00459	0.109	CrCbGaD
Triflupromazine—DRD2—midbrain—narcolepsy	0.00447	0.0357	CbGeAlD
Triflupromazine—BCHE—medulla oblongata—narcolepsy	0.00443	0.0354	CbGeAlD
Triflupromazine—BCHE—midbrain—narcolepsy	0.00405	0.0324	CbGeAlD
Triflupromazine—CHRM2—brain—narcolepsy	0.00383	0.0306	CbGeAlD
Triflupromazine—CHRM1—brain—narcolepsy	0.00349	0.0278	CbGeAlD
Triflupromazine—HTR2B—brain—narcolepsy	0.00347	0.0277	CbGeAlD
Triflupromazine—Acepromazine—HTR2A—narcolepsy	0.00295	0.0703	CrCbGaD
Triflupromazine—ABCB1—forebrain—narcolepsy	0.00292	0.0234	CbGeAlD
Triflupromazine—Thioproperazine—HTR2A—narcolepsy	0.00288	0.0687	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—narcolepsy	0.00283	0.0676	CrCbGaD
Triflupromazine—DRD2—brain—narcolepsy	0.00281	0.0224	CbGeAlD
Triflupromazine—Mesoridazine—HTR2A—narcolepsy	0.0028	0.0667	CrCbGaD
Triflupromazine—BCHE—brain—narcolepsy	0.00255	0.0203	CbGeAlD
Triflupromazine—Fluphenazine—HTR2A—narcolepsy	0.00245	0.0584	CrCbGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00242	0.00291	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00242	0.0029	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00242	0.0029	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00237	0.00284	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00237	0.00284	CbGpPWpGaD
Triflupromazine—Propiomazine—HTR2A—narcolepsy	0.00236	0.0562	CrCbGaD
Triflupromazine—DRD1—GPCR ligand binding—PENK—narcolepsy	0.00234	0.00281	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00234	0.0028	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00234	0.0028	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00233	0.0028	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00232	0.00279	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00229	0.00275	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00228	0.00274	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00227	0.00273	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00226	0.00271	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00224	0.0027	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00224	0.00269	CbGpPWpGaD
Triflupromazine—Clomipramine—HTR2A—narcolepsy	0.00224	0.0534	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—narcolepsy	0.00223	0.0532	CrCbGaD
Triflupromazine—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00218	0.00262	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00212	0.00255	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00212	0.00255	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—TRH—narcolepsy	0.00211	0.00254	CbGpPWpGaD
Triflupromazine—ABCB1—medulla oblongata—narcolepsy	0.00211	0.0169	CbGeAlD
Triflupromazine—Thioridazine—HTR2A—narcolepsy	0.00211	0.0503	CrCbGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.0021	0.00253	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00206	0.00247	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00205	0.00246	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00202	0.00243	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00202	0.00242	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00202	0.00242	CbGpPWpGaD
Triflupromazine—Methotrimeprazine—HTR2A—narcolepsy	0.00201	0.048	CrCbGaD
Triflupromazine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.002	0.0024	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—TRH—narcolepsy	0.00199	0.00239	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.00199	0.00238	CbGpPWpGaD
Triflupromazine—Promethazine—HTR2A—narcolepsy	0.00198	0.0473	CrCbGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00198	0.00238	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00198	0.00237	CbGpPWpGaD
Triflupromazine—Trifluoperazine—HTR2A—narcolepsy	0.00196	0.0467	CrCbGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00195	0.00235	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00194	0.00233	CbGpPWpGaD
Triflupromazine—Perphenazine—HTR2A—narcolepsy	0.00194	0.0462	CrCbGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00193	0.00232	CbGpPWpGaD
Triflupromazine—ABCB1—midbrain—narcolepsy	0.00193	0.0154	CbGeAlD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00193	0.00231	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00192	0.00231	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00192	0.0023	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00192	0.0023	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00192	0.0023	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00191	0.00229	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0019	0.00228	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0019	0.00228	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0019	0.00228	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0019	0.00228	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00185	0.00222	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.00185	0.00222	CbGpPWpGaD
Triflupromazine—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00183	0.0022	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00181	0.00217	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00181	0.00217	CbGpPWpGaD
Triflupromazine—Desipramine—HTR2A—narcolepsy	0.0018	0.043	CrCbGaD
Triflupromazine—DRD2—GPCR ligand binding—PENK—narcolepsy	0.00177	0.00212	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00175	0.0021	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—HRH3—narcolepsy	0.00175	0.0021	CbGpPWpGaD
Triflupromazine—Promazine—HTR2A—narcolepsy	0.00175	0.0416	CrCbGaD
Triflupromazine—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00174	0.00209	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00174	0.00209	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00173	0.00208	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00173	0.00208	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00171	0.00205	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0017	0.00204	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.00168	0.00202	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00167	0.00201	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00164	0.00197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00164	0.00197	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00164	0.00197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00159	0.00191	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.00158	0.00189	CbGpPWpGaD
Triflupromazine—Chlorpromazine—HTR2A—narcolepsy	0.00154	0.0366	CrCbGaD
Triflupromazine—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.00154	0.00184	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.00154	0.00184	CbGpPWpGaD
Triflupromazine—Imipramine—HTR2A—narcolepsy	0.00153	0.0364	CrCbGaD
Triflupromazine—DRD2—GPCR ligand binding—TRH—narcolepsy	0.0015	0.00181	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00149	0.00178	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00147	0.00177	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00146	0.00176	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00146	0.00175	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00145	0.00175	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—TAC1—narcolepsy	0.00145	0.00174	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—NPS—narcolepsy	0.00145	0.00174	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00144	0.00172	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00144	0.00172	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.00143	0.00172	CbGpPWpGaD
Triflupromazine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00142	0.0017	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0014	0.00169	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0014	0.00169	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.0014	0.00169	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00139	0.00167	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00139	0.00167	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00137	0.00164	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00137	0.00164	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HCRT—narcolepsy	0.00135	0.00162	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00134	0.00161	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00134	0.00161	CbGpPWpGaD
Triflupromazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00134	0.0016	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PENK—narcolepsy	0.00132	0.00159	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00132	0.00158	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00132	0.00158	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.00132	0.00158	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.00132	0.00158	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00129	0.00155	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00129	0.00155	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00128	0.00153	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.00128	0.00153	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00127	0.00153	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00127	0.00153	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CHKB—narcolepsy	0.00126	0.00152	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.00124	0.00149	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.00124	0.00149	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00121	0.00146	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00121	0.00146	CbGpPWpGaD
Triflupromazine—ABCB1—brain—narcolepsy	0.00121	0.00969	CbGeAlD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00121	0.00146	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PENK—narcolepsy	0.0012	0.00144	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.0012	0.00144	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.0012	0.00144	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.0012	0.00144	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.00119	0.00143	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00117	0.00141	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00116	0.00139	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00114	0.00137	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00114	0.00137	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—TRH—narcolepsy	0.00113	0.00135	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00135	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.0011	0.00132	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00131	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00131	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.00108	0.0013	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00108	0.0013	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00107	0.00128	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00107	0.00128	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00106	0.00127	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00106	0.00127	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.00105	0.00126	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.00103	0.00124	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.00103	0.00124	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—TRH—narcolepsy	0.00102	0.00123	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.00102	0.00122	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00101	0.00121	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.001	0.0012	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.000997	0.0012	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.000994	0.00119	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000987	0.00119	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000986	0.00118	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.000984	0.00118	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.000979	0.00117	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000974	0.00117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000971	0.00117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000971	0.00117	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.000966	0.00116	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.000951	0.00114	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—P2RY11—narcolepsy	0.000937	0.00113	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.000924	0.00111	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000908	0.00109	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HRH3—narcolepsy	0.000897	0.00108	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.000889	0.00107	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.000877	0.00105	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000871	0.00105	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.000868	0.00104	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.000868	0.00104	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000864	0.00104	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CPT1B—narcolepsy	0.000859	0.00103	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.00085	0.00102	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.000845	0.00101	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000845	0.00101	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000834	0.001	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.000832	0.000999	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.000821	0.000986	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000818	0.000982	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—NPS—narcolepsy	0.000818	0.000982	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HCRT—narcolepsy	0.000797	0.000957	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—TAC1—narcolepsy	0.000788	0.000946	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—NPS—narcolepsy	0.000788	0.000946	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000772	0.000927	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000756	0.000907	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PENK—narcolepsy	0.000753	0.000905	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000746	0.000896	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000746	0.000895	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—TAC1—narcolepsy	0.000743	0.000892	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—NPS—narcolepsy	0.000743	0.000892	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000733	0.00088	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000733	0.00088	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00073	0.000876	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00072	0.000865	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000717	0.000861	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000717	0.000861	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PENK—narcolepsy	0.00071	0.000853	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000708	0.00085	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000708	0.00085	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000708	0.00085	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000693	0.000832	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000692	0.00083	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000684	0.000821	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.000677	0.000813	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000663	0.000796	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000658	0.00079	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000654	0.000785	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000644	0.000773	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TRH—narcolepsy	0.000641	0.000769	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000635	0.000763	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000626	0.000752	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000618	0.000742	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000618	0.000742	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CHKB—narcolepsy	0.000616	0.00074	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000605	0.000726	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000605	0.000726	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TRH—narcolepsy	0.000604	0.000725	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HCRT—narcolepsy	0.000602	0.000723	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000597	0.000717	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000597	0.000717	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000589	0.000707	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000581	0.000698	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HRH3—narcolepsy	0.000562	0.000674	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—NPS—narcolepsy	0.000561	0.000674	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.000561	0.000674	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000549	0.000659	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000549	0.000659	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000542	0.000651	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000542	0.000651	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PENK—narcolepsy	0.000536	0.000644	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HRH3—narcolepsy	0.00053	0.000636	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000525	0.00063	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000522	0.000627	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000518	0.000622	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000492	0.000591	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	0.000474	0.000569	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NPS—narcolepsy	0.000465	0.000559	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TAC1—narcolepsy	0.000465	0.000559	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TRH—narcolepsy	0.000456	0.000548	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000447	0.000537	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000446	0.000536	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000441	0.000529	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TAC1—narcolepsy	0.000439	0.000527	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NPS—narcolepsy	0.000439	0.000527	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000419	0.000503	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HRH3—narcolepsy	0.0004	0.00048	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000391	0.00047	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000386	0.000464	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000372	0.000446	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000364	0.000437	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000359	0.000431	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000341	0.00041	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.000337	0.000405	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TAC1—narcolepsy	0.000331	0.000398	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NPS—narcolepsy	0.000331	0.000398	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.00033	0.000397	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000326	0.000391	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000324	0.000389	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000324	0.000389	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.00032	0.000384	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.00032	0.000384	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—narcolepsy	0.00028	0.000336	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—narcolepsy	0.000264	0.000317	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000199	0.000239	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000195	0.000234	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000193	0.000231	CbGpPWpGaD
